Development of AI-Powered Diagnostic System for Rapid Pathogen Identification

Thesis Abstract

The rapid and accurate identification of pathogenic microorganisms is a critical challenge in clinical microbiology, particularly in the context of emerging infectious diseases and antibiotic resistance. Traditional diagnostic methods such as culture and PCR, although reliable, often require extensive time, specialized laboratory settings, and skilled personnel, leading to delays in diagnosis and treatment initiation. Addressing this critical gap, the study aims to develop an artificial intelligence (AI)-powered diagnostic system that facilitates swift, precise pathogen identification directly from clinical samples, thereby enhancing response times and patient outcomes. The primary objectives are to design and implement a machine learning framework capable of classifying pathogens based on genomic and phenotypic data, to evaluate the system’s diagnostic accuracy against gold-standard laboratory tests, and to assess its operational practicality in diverse clinical settings. Specifically, the research seeks to explore the feasibility of AI models, such as convolutional neural networks (CNNs) and random forest classifiers, in integrating heterogeneous data sources for pathogen detection. Additionally, the study aims to identify performance determinants and potential limitations affecting real-world deployment of such systems. Adopting a quantitative research design, the study utilizes a cross-sectional approach incorporating a large dataset of 10,000 anonymized clinical samples collected from microbiology laboratories across a regional healthcare network. These samples include bacterial, fungal, and viral pathogens, with confirmed identifications obtained through conventional methods serving as baseline standards. The population comprises clinical microbiology specimens from both adult and pediatric patients, with stratified random sampling employed to ensure representative diversity. Data collection involves extracting genomic sequences, phenotypic trait profiles, and laboratory test results stored in hospital databases and genomic repositories. The AI models are trained and validated using supervised learning techniques, with 70% of the data allocated for training and 30% for testing. Model performance is assessed via metrics including sensitivity, specificity, accuracy, and area under the receiver operating characteristic curve (AUC-ROC). To ensure robustness, hyperparameter tuning is conducted through grid search optimization, while model explainability is enhanced via SHapley Additive exPlanations (SHAP) analysis. Additionally, statistical analyses such as receiver operating characteristic (ROC) analysis and confusion matrices are employed to compare AI predictions with standard diagnostic outcomes. Ethical approval is obtained from relevant institutional review boards, emphasizing data anonymization and compliance with healthcare privacy regulations. Anticipated findings include high diagnostic accuracy of AI models, with sensitivity and specificity exceeding 95%, demonstrating their potential to rival traditional methods in pathogen detection. The study expects to identify key genomic and phenotypic features contributing to model predictions, offering insights into pathogen characteristics. The research aims to confirm the viability of AI-based systems as rapid, cost-effective, and scalable alternatives for microbiological diagnostics in frontline healthcare environments, particularly in resource-limited settings. This study substantially contributes to the knowledge base by integrating advances in machine learning with microbiological diagnostics, thus advancing personalized medicine and infection control strategies. The findings are expected to inform policy development on deploying AI-enabled diagnostic tools within clinical workflows and fostering further innovations in digital microbiology. The main conclusion underscores the transformative potential of AI-driven diagnostic systems to shorten turnaround times, improve diagnostic accuracy, and strengthen global infectious disease management. Recommendations advocate for continued refinement of algorithms, broader validation across different pathogens and populations, and integration with existing laboratory information systems to ensure seamless adoption and sustainability in healthcare practices. Future research directions include exploring multi-modal data fusion, real-time point-of-care implementation, and embedding AI systems within electronic health record platforms.